2.1% to 2.6% of patients given Qnexa (phentermine + Topamax) dropped out due to cognitive effects

Posted by .(JavaScript must be enabled to view this email address)
Thursday, October 29, 2009 1:42 pm Email this article
Among patients given a full dose of Qnexa (15 mg Phentermine plus 92 mg Topamax), 2.1% and 2.6% dropped out of two study due to cognitive side effects such as "disturbance in attention" or "forgetfulness" compared to 0.3% and 0.8% of those given the placebo reports TheStreet.com.

This had not been previously disclosed by Vivus, the company developing this drug.

Other articles about Qnexa are posted here.

Articles on the same subject can be found here:

• Qsymia (phentermine and topiramate) (formerly Qnexa)